More than half of all clinical trials fail due to safety issues, but what happens then?
In this episode, we sit down with Dr. Layla Hosseini-Gerami, Chief Data Science Officer at Ignota Labs, who bridges the world of biology, chemistry, and AI to understand modes of drug toxicity. She describes how her work at Ignota Labs aims to rescue failing drug candidates and bring new hope to patients.
We explore the growing use of machine learning in the life sciences, and how multidisciplinary science is critical for the success of bench-to-bedside drug development. 💊
Layla was named to the Forbes 30 Under 30 Europe Class of 2025 in Science & Healthcare. Click the link below to read the full article.
Forbes 30 Under 30: https://lnkd.in/ebDWXXXa
Follow us on social media: